EWG Elevate’s Boston Scientific BSX Stock Holding History

EWG Elevate’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28	Closed	-$1.3K	–	160
2022 Q4	$1.3K	Buy	+28	New	+$1.21K	﹤0.01%	642

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EWG Elevate's BSX Position: Q1 2023 in Review

EWG Elevate sold out of Boston Scientific (BSX) in Q1 2023, closing a stake of 28 shares — an estimated $1.3K sold.

EWG Elevate first reported a position in BSX in Q4 2022 and held it in 1 quarter. The position peaked at $1.3K in Q4 2022. 996 funds tracked by Wall St. Rank hold BSX as of Q1 2023.

EWG Elevate reported no remaining Boston Scientific position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 28 Boston Scientific shares in Q1 2023, an estimated $1.3K.
EWG Elevate first reported a position in Boston Scientific in Q4 2022 and held it in 1 quarter.
EWG Elevate's Boston Scientific position peaked at $1.3K in Q4 2022.
996 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.